Stay updated on Dabrafenib Trametinib in BRAF Mutant Melanoma Clinical Trial
Sign up to get notified when there's something new on the Dabrafenib Trametinib in BRAF Mutant Melanoma Clinical Trial page.

Latest updates to the Dabrafenib Trametinib in BRAF Mutant Melanoma Clinical Trial page
- Check6 days agoChange DetectedNew history entries were added for 2026-04-08 to 2026-04-13, including a Study Status update and additional version numbers (1009–1011).SummaryDifference0.0%

- Check13 days agoChange DetectedNew history entries were added documenting updates to Study Status and Contacts/Locations. The updates span from 2026-03-21 to 2026-04-06.SummaryDifference0.2%

- Check28 days agoChange DetectedNew history entries were added for 2026-03-14 through 2026-03-20, including revision v3.5.0. The previous revision v3.4.3 was removed.SummaryDifference0.1%

- Check36 days agoChange DetectedNew history entries were added for Study Status (IDs 987–991). The entries cover dates from 2026-03-07 to 2026-03-13.SummaryDifference0.1%

- Check43 days agoChange DetectedNew revision entries were added to the history (including v3.4.3), and the older v3.4.2 entry was removed.SummaryDifference0.1%

- Check50 days agoChange DetectedNew history entries were added for the record, showing recent Study Status updates (versions 977–981) with their submission dates. This reflects record-keeping activity rather than changes to core study content.SummaryDifference0.1%

Stay in the know with updates to Dabrafenib Trametinib in BRAF Mutant Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dabrafenib Trametinib in BRAF Mutant Melanoma Clinical Trial page.